523 related articles for article (PubMed ID: 19147999)
1. Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost.
Pellinen P; Lokkila J
Ophthalmic Res; 2009; 41(2):118-22. PubMed ID: 19147999
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers.
Uusitalo H; Kaarniranta K; Ropo A
Acta Ophthalmol Suppl (Oxf ); 2008; 242():7-13. PubMed ID: 18752509
[TBL] [Abstract][Full Text] [Related]
3. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
[TBL] [Abstract][Full Text] [Related]
5. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
6. Disposition and metabolism of a novel prostanoid antiglaucoma medication, tafluprost, following ocular administration to rats.
Fukano Y; Kawazu K
Drug Metab Dispos; 2009 Aug; 37(8):1622-34. PubMed ID: 19477946
[TBL] [Abstract][Full Text] [Related]
7. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Ocular Pharmacokinetics Study of Preservative-Free Latanoprost Unit-Dose Eye Drops and a Benzalkonium Chloride-Preserved Branded Product Following Topical Application to Rabbits.
Zhou T; Miao Y; Li Z; Lu P; Liang Z; Yang J; He J; Xia H; Zhang Z; Zhang J
J Ocul Pharmacol Ther; 2020 Sep; 36(7):522-528. PubMed ID: 32310714
[No Abstract] [Full Text] [Related]
9. Effects of the preservative purite on the bioavailability of brimonidine in the aqueous humor of rabbits.
Dong JQ; Babusis DM; Welty DF; Acheampong AA; Tang-Liu D; Whitcup SM
J Ocul Pharmacol Ther; 2004 Aug; 20(4):285-92. PubMed ID: 15321023
[TBL] [Abstract][Full Text] [Related]
10. Corneal and aqueous humor concentrations of amphotericin B using three different routes of administration in a rabbit model.
Qu L; Li L; Xie H
Ophthalmic Res; 2010; 43(3):153-8. PubMed ID: 19887881
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
12. Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension.
Swymer C; Neville MW
Ann Pharmacother; 2012 Nov; 46(11):1506-10. PubMed ID: 23092867
[TBL] [Abstract][Full Text] [Related]
13. The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution.
Fukuda M; Inoue A; Sasaki K; Takahashi N
Jpn J Ophthalmol; 2004; 48(2):93-6. PubMed ID: 15060787
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride.
Liang H; Baudouin C; Pauly A; Brignole-Baudouin F
Br J Ophthalmol; 2008 Sep; 92(9):1275-82. PubMed ID: 18723745
[TBL] [Abstract][Full Text] [Related]
15. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
16. Benefits of Tafluprost and Timolol Fixed-Dose Combination for the Treatment of Glaucoma Are Confirmed by Studies on Experimental Animal Models.
Akaishi T; Shimazaki A; Tonouchi A; Ueda K; Miyawaki N; Kawazu K
J Ocul Pharmacol Ther; 2015 Nov; 31(9):518-24. PubMed ID: 26325164
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost.
Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
Clin Exp Ophthalmol; 2015 Mar; 43(2):164-72. PubMed ID: 25041649
[TBL] [Abstract][Full Text] [Related]
18. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
19. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation.
Pauly A; Roubeix C; Liang H; Brignole-Baudouin F; Baudouin C
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8172-80. PubMed ID: 23150620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]